Browse diseases

…f Tregs and in metastasis.Results Aging significantly increased melanoma colonization in both the lungs and liver compared to young mice…

…ng a delay in surgery due to treatment-related toxicity, namely myositis. A pathological response was observed in 98% of patients, with …

…ed pretreatment serum samples from 331 patients with metastatic melanoma treated with anti-CTLA-4 (ipilimumab), anti-PD-1 (pembrolizumab…

…ntitumor immune responses in various cancer entities, including melanoma. While immune checkpoint blockade (ICB) using the antagonistic …

…ab to treat non-small cell lung cancer, and pemetrexed to treat non-small cell lung cancer) accounted for 68.4% (n=52 107 years) of the total life year ga…

…rhage.A second cerebrospinal fluid analysis confirmed malignant melanoma cells, establishing the diagnosis of malignant meningitis secon…

…Background Choroidal melanoma can arise from malignant transformation of choroidal nevus. The…

…erapies targeting proteins such as CTLA-4 or LAG-3.bDrawings of melanoma and sites of metastases are for illustrative purposes only and …

…pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy bioma…

…tterns (defined as uptake <50% of maximum). In one patient with NSCLC, baseline PET showed necrotic LV segments that exhibited elevat…

…or immunity and ICI efficacy in a translationally relevant BRAF melanoma tumor model which is ICI resistant.Results We first show that e…

…ated with improved survival and enhanced immune infiltration in melanoma. Their expression predicts response to checkpoint inhibitors. F…